NOLATO AB |
Market Closed -
Other stock markets
|
After market 08:55:00 pm | |||
| 44.82 SEK | -18.66% |
|
60.28 | +34.48% |
| 06/05 | Nordic Stocks Moved Upward Monday; Nolato Series B Led Increases | DJ |
| 06/05 | Nolato AB Elects Klas Forsström as Ordinary Board Member | CI |
| Sales 2024 * | 9.95B 945M 78.86B | Sales 2025 * | 10.54B 1B 83.48B | Capitalization | 16.14B 1.53B 128B |
|---|---|---|---|---|---|
| Net income 2024 * | 699M 66.35M 5.54B | Net income 2025 * | 785M 74.52M 6.22B | EV / Sales 2024 * | 1.75 x |
| Net Debt 2024 * | 1.31B 125M 10.4B | Net Debt 2025 * | 1.22B 116M 9.67B | EV / Sales 2025 * | 1.65 x |
| P/E ratio 2024 * |
23.1
x | P/E ratio 2025 * |
20.6
x | Employees | 5,552 |
| Yield 2024 * |
2.8% | Yield 2025 * |
3.21% | Free-Float | 71.42% |
More Fundamentals
* Assessed data
More news
Latest transcript on Nolato AB
More press releases
More news
| 1 day | +34.48% | ||
| 1 week | -26.58% | ||
| Current month | -27.48% | ||
| 1 month | -23.09% | ||
| 3 months | +6.11% | ||
| 6 months | -15.43% | ||
| Current year | -15.67% |
1 week
44.82
62.45
1 month
44.8262.45
Current year
41.8862.45
1 year
40.4062.45
3 years
40.40121.20
5 years
36.70121.20
10 years
13.53121.20
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/96/01 | |
| Director of Finance/CFO | 60 | 01/95/01 | |
Björn Jacobsson
BRD | Director/Board Member | 53 | 01/00/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 71 | 01/05/01 | |
| Chairman | 71 | 01/09/01 | |
| Chief Executive Officer | 53 | 01/96/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/24/05 | 60 | +0.25% | 5,605 |
| 04/24/04 | 59.85 | -0.42% | 1,165 |
| 03/24/03 | 60.1 | -2.75% | 5,475 |
| 31/24/31 | 61.8 | +1.23% | 8,762 |
| 30/24/30 | 61.05 | +1.08% | 18,378 |
Delayed Quote London S.E., September 29, 2023 at 09:07 pm IST
More quotes
Nolato AB is a Sweden-based company engaged in the development and manufacture of polymer product systems for customers in medical technology, pharmaceuticals, consumer electronics, telecom, automotive products, hygiene and other industrial sectors. The Companyâs operations are divided into three operating segments. The Medical Solutions segment develops and manufactures complex product systems and components for medical devices, the pharmaceutical industry and diagnostics. The Integrated Solutions segments offers a wide range of technologies and expertise in a one-stop shop for areas including injection molding, casting, die-cutting, painting, decoration, assembly, testing and packaging of electronic products. The Industrial Solutionssegment develops and manufactures components and product systems for customers in the automotive industry, hygiene, packaging, gardening/ forestry, domestic appliances, furniture and other selected industrial segments. The Company operates worldwide.
Sector
Specialty Chemicals
Calendar
18/07/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
59.9
SEK
Average target price
59
SEK
Spread / Average Target
-1.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.70% | 5.44B | |
| +3.03% | 4.12B | |
| -5.29% | 1.22B | |
| +23.04% | 967M | |
| -18.27% | 617M | |
| -40.32% | 525M | |
| -22.14% | 253M | |
| -7.09% | 251M | |
| -19.47% | 222M |
- Stock Market
- Equities
- NOLA B Stock
- 0OA9 Stock
